IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication

• Published in: Journal of viral hepatitis 2013-04, Vol.20 (4), p.281-289
• Main Authors: Shindo, H., Maekawa, S., Komase, K., Miura, M., Kadokura, M., Sueki, R., Komatsu, N., Shindo, K., Amemiya, F., Nakayama, Y., Inoue, T., Sakamoto, M., Yamashita, A., Moriishi, K., Enomoto, N.
• Format: Article
• Language: English
• Subjects: Antiviral Agents - pharmacology; Biological Products - pharmacology; Cell Line; Drug Synergism; Gene Expression Profiling; HCV; Hepacivirus - drug effects; Hepacivirus - physiology; Hepatitis C virus; Hepatocytes - immunology; Hepatocytes - virology; Humans; IFN-λ; IL-28B; Interferon-alpha - pharmacology; Interferons; Interleukins - pharmacology; ISG; microarray; Microarray Analysis; synergistic inhibition; Virus Replication - drug effects
• ISSN: 1352-0504; 1365-2893
• DOI: 10.1111/j.1365-2893.2012.01649.x

Summary Genetic variation in the IL‐28B (interleukin‐28B; interferon lambda 3) region has been associated with sustained virological response (SVR) rates in patients with chronic hepatitis C treated with peginterferon‐α and ribavirin. However, the mechanisms by which polymorphisms in the IL‐28B gene region affect host antiviral responses are not well understood. Using the HCV 1b and 2a replicon system, we compared the effects of IFN‐λs and IFN‐α on HCV RNA replication. The anti‐HCV effect of IFN‐λ3 and IFN‐α in combination was also assessed. Changes in gene expression induced by IFN‐λ3 and IFN‐α were compared using cDNA microarray analysis. IFN‐λs at concentrations of 1 ng/mL or more exhibited concentration‐ and time‐dependent HCV inhibition. In combination, IFN‐λ3 and IFN‐α had a synergistic anti‐HCV effect; however, no synergistic enhancement was observed for interferon‐stimulated response element (ISRE) activity or upregulation of interferon‐stimulated genes (ISGs). With respect to the time course of ISG upregulation, the peak of IFN‐λ3‐induced gene expression occurred later and lasted longer than that induced by IFN‐α. In addition, although the genes upregulated by IFN‐α and IFN‐λ3 were similar to microarray analysis, interferon‐stimulated gene expression appeared early and was prolonged by combined administration of these two IFNs. In conclusion, IFN‐α and IFN‐λ3 in combination showed synergistic anti‐HCV activity in vitro. Differences in time‐dependent upregulation of these genes might contribute to the synergistic antiviral activity.